Immunogenicity 14726
Sample ID
3784
Response
Negative
Tumor Type
Melanoma
Gene Symbol
SLC30A5
Transcript ID
NM_022902
HLA INFO
A*03:01
TCR INFO
No TCR info found!
Full length protein sequence (765 aa)
MEEKY
1
GGDVL
6
AGPGG
11
GGGLG
16
PVDVP
21
SARLT
26
KYIVL
31
LCFTK
36
FLKAV
41
GLFES
46
YDLLK
51
AVHIV
56
QFIFI
61
LKLGT
66
AFFMV
71
LFQKP
76
FSSGK
81
TITKH
86
QWIKI
91
FKHAV
96
AGCII
101
SLLWF
106
FGLTL
111
CGPLR
116
TLLLF
121
EHSDI
126
VVISL
131
LSVLF
136
TSSGG
141
GPAKT
146
RGAAF
151
FIIAV
156
ICLLL
161
FDNDD
166
LMAKM
171
AEHPE
176
GHHDS
181
ALTHM
186
LYTAI
191
AFLGV
196
ADHKG
201
GVLLL
206
VLALC
211
CKVGF
216
HTASR
221
KLSVD
226
VGGAK
231
RLQAL
236
SHLVS
241
VLLLC
246
PWVIV
251
LSVTT
256
ESKVE
261
SWFSL
266
IMPFA
271
TVIFF
276
VMILD
281
FYVDS
286
ICSVK
291
MEVSK
296
CARYG
301
SFPIF
306
ISALL
311
FGNFW
316
THPIT
321
DQLRA
326
MNKAA
331
HQEST
336
EHVLS
341
GGVVV
346
SAIFF
351
ILSAN
356
ILSSP
361
SKRGQ
366
KGTLI
371
GYSPE
376
GTPLY
381
NFMGD
386
AFQHS
391
SQSIP
396
RFIKE
401
SLKQI
406
LEESD
411
SRQIF
416
YFLCL
421
NLLFT
426
FVELF
431
YGVLT
436
NSLGL
441
ISDGF
446
HMLFD
451
CSALV
456
MGLFA
461
ALMSR
466
WKATR
471
IFSYG
476
YGRIE
481
ILSGF
486
INGLF
491
LIVIA
496
FFVFM
501
ESVAR
506
LIDPP
511
ELDTH
516
MLTPV
521
SVGGL
526
IVNLI
531
GICAF
536
SHAHS
541
HAHGA
546
SQGSC
551
HSSDH
556
SHSHH
561
MHGHS
566
DHGHG
571
HSHGS
576
AGGGM
581
NANMR
586
GVFLH
591
VLADT
596
LGSIG
601
VIVST
606
VLIEQ
611
FGWFI
616
ADPLC
621
SLFIA
626
ILIFL
631
SVVPL
636
IKDAC
641
QVLLL
646
RLPPE
651
YEKEL
656
HIALE
661
KIQKI
666
EGLIS
671
YRDPH
676
FWRHS
681
ASIVA
686
GTIHI
691
QVTSD
696
VLEQR
701
IVQQV
706
TGILK
711
DAGVN
716
NLTIQ
721
VEKEA
726
YFQHM
731
SGLST
736
GFHDV
741
LAMTK
746
QMESM
751
KYCKD
756
GTYIM
761
Mutation Information
DNA mutation:
None
Peptide Range:
582 ~ 606
Mut AA position:
594 (13 in Wild Type peptide)
Alignment
Wild Type:
"GGGMNANMRGVFLHVLADTLGSIGV
||||||||||||.||||||||||||
Mutant:
GGGMNANMRGVFPHVLADTLGSIGV"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) SLC30A5
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay